Evidence map›Paper›PMID 26038567›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Virus-induced translational arrest through 4EBP1/2-dependent decay of 5'-TOP mRNAs restricts viral infection.

Kaycie C Hopkins, Michael A Tartell, Christin Herrmann, Brent A Hackett, Frances Taschuk, Debasis Panda, Sanjay V Menghani, Leah R Sabin, Sara Cherry

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Strategies for Success. Viral Infections and Membraneless Organelles.Frontiers in cellular and infection microbiology · 2019
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kaycie C HopkinsDepartment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104;
Michael A TartellDepartment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104;
Christin HerrmannDepartment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104;
Brent A HackettDepartment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104;
Frances TaschukDepartment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104;
Debasis PandaDepartment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104;
Sanjay V MenghaniDepartment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104;
Leah R SabinWatson School of Biological Sciences, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724.
Sara CherryDepartment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104; cherrys@mail.med.upenn.edu.
University of Pennsylvania · USCold Spring Harbor Laboratory · US

Funding

Vaccine strategy for broad spectrum protection agains non-typhoidal salmonellU54AI057168 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LEVINE, MYRON MAX · 2003 to 2013
$91.5M
TRAINING PROGRAM IN CELL AND MOLECULAR BIOLOGYT32GM007229 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI BARTOLOMEI, MARISA S. · 1985 to 2023
$14.0M
The role of autophagy in innate anti-viral immunity in DrosophilaR01AI074951 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHERRY, SARA · 2007 to 2017
$4.2M
TRAINING IN NEUROVIROLOGY AND NEUROIMMUNOLOGYT32NS007180 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI WEISS, SUSAN R · 1985 to 2018
$2.8M
Dissecting the alphavirus entry receptor NRAMPR01AI095500 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHERRY, SARA · 2012 to 2015
$1.9M
NIAID NIH HHS R01 AI074951NIAID NIH HHS R01AI074951NIAID NIH HHS R01 AI095500NIAID NIH HHS R01AI095500NIAID NIH HHS U54 AI057168NIAID NIH HHS U54AI057168NIGMS NIH HHS T32 GM007229NINDS NIH HHS T32 NS007180
6 · The paper itself

Abstract

The mosquito-transmitted bunyavirus, Rift Valley fever virus (RVFV), is a highly successful pathogen for which there are no vaccines or therapeutics. Translational arrest is a common antiviral strategy used by hosts. In response, RVFV inhibits two well-known antiviral pathways that attenuate translation during infection, PKR and type I IFN signaling. Despite this, translational arrest occurs during RVFV infection by unknown mechanisms. Here, we find that RVFV infection triggers the decay of core translation machinery mRNAs that possess a 5'-terminal oligopyrimidine (5'-TOP) motif in their 5'-UTR, including mRNAs encoding ribosomal proteins, which leads to a decrease in overall ribosomal protein levels. We find that the RNA decapping enzyme NUDT16 selectively degrades 5'-TOP mRNAs during RVFV infection and this decay is triggered in response to mTOR attenuation via the translational repressor 4EBP1/2 axis. Translational arrest of 5'-TOPs via 4EBP1/2 restricts RVFV replication, and this increased RNA decay results in the loss of visible RNA granules, including P bodies and stress granules. Because RVFV cap-snatches in RNA granules, the increased level of 5'-TOP mRNAs in this compartment leads to snatching of these targets, which are translationally suppressed during infection. Therefore, translation of RVFV mRNAs is compromised by multiple mechanisms during infection. Together, these data present a previously unknown mechanism for translational shutdown in response to viral infection and identify mTOR attenuation as a potential therapeutic avenue against bunyaviral infection.

Indexed as

Adaptor Proteins, Signal TransducingCell Cycle ProteinsCell LineDNA PrimersElectrophoresis, Polyacrylamide GelFluorescent Antibody TechniqueHumansImmunoblottingLinear ModelsLuciferasesPhosphoproteinsProtein BiosynthesisPyrophosphatasesReverse Transcriptase Polymerase Chain ReactionRift Valley FeverRift Valley fever virusAdaptor Proteins, Signal TransducingCell Cycle ProteinsDNA PrimersEIF4EBP1 protein, humanLuciferasesMTOR protein, humanNudt16 protein, humanPhosphoproteinsPyrophosphatasesRNA, MessengerRNA, Small InterferingTOR Serine-Threonine Kinases5′-TOP mRNARift Valley fever virusRNA decayRNA granuletranslational arrest

Identifiers

PMID26038567
PMCPMC4460451
OpenAlexW1847017836

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.